NLRP3 and noise induced hearing loss: In 2023, Chen et al. [62] proposed that Ori administration could enhance ILR2 concentration by specifically blocking the assembly and activation of NLRP3 inflammasomes, and thus having an anti-inflammatory effect on rats exposed to NIHL.